Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review.
about
Persistence and compliance with medication management in the treatment of overactive bladderPrevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT).Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample.CUA guideline on adult overactive bladderCrucial role of TRPC1 and TRPC4 in cystitis-induced neuronal sprouting and bladder overactivity.Postmenopausal overactive bladderAnalysis of the usage of continence pads and help-seeking behavior of women with stress urinary incontinence in Poland.Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors.Factors associated with persistent urinary incontinence.Epidemiology of mixed, stress, and urgency urinary incontinence in middle-aged/older women: the importance of incontinence historyIncidence of lower urinary tract symptoms in a population-based study of men and womenPercutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study.Novel biomarkers for overactive bladder.Management of OAB in those over age 65.Comorbidities and personal burden of urgency urinary incontinence: a systematic review.Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.A Behavioral Weight Loss Program and Non-Urinary Incontinence Lower Urinary Tract Symptoms in Overweight and Obese Women with Urinary Incontinence: A Secondary Data Analysis of the Program to Reduce Incontinence by Diet and Exercise (PRIDE).The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older.Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence.Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.Drugs for the overactive bladder: are there differences in persistence and compliance?Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.A Prospective Study of the Natural History of Urinary Incontinence in Women.The natural history of the overactive bladder syndrome in females: a long-term analysis of a health screening project.Epidemiology of stress urinary incontinence in women.Long-term outcomes of transobturator tapes in women with stress urinary incontinence: E-TOT randomised controlled trial.
P2860
Q26765014-EB0B50E7-D05A-4B96-8A5F-20803D716F48Q30636369-10D7EBBE-042E-4B27-9157-56CE8BD3D831Q33575431-899BCA5A-C376-4869-A2B3-042961F0D4DDQ33665026-2BF8F9E1-30E4-481A-B76D-0D0D0522BB3BQ34902996-EF1CAED0-BB2E-4E9C-8CBB-A46DD3BBE957Q35157329-D7A33084-DA58-4418-AA8C-2683EAE7BC60Q35794119-7EBCE524-71AD-47A5-8165-D9D55DF8B7B9Q36048213-2BA5C7F6-9F6E-48ED-AAAD-5EA8954C3CC6Q37060422-D96F31E7-F195-4DC2-BDB9-11833CB629DAQ37119597-796D0BE3-8A6C-4DD2-A36D-E9B0BD8A8E19Q37136308-F2CFDA93-C6E8-4258-9D42-46DAFF0D69B4Q37626517-6EAB8F0D-5D6B-4A2B-9DE1-28AAA0280BCCQ37842130-E27ECFDD-4DCC-4156-A3BA-1A4AEB9C443CQ38127155-E3410873-BD15-469D-8F9B-C17E3259C290Q38145376-AF5BE88D-B1B5-4937-B1E3-EED080F089B7Q38352217-F2DD235A-D427-4285-B5CB-A68D7156FE32Q38625194-F3212617-4F9E-490B-B15D-939CA31F6970Q38668143-A35A4961-0B00-4CD5-BECC-DC6F39977DD5Q38669033-7C6EDFFE-FFB6-48DA-9057-4E1A2E6E41BBQ39037375-D3B2D9F4-51A3-4ED5-99AE-DB6272462EC0Q39060225-5A0C32C5-DC85-4E2E-B921-27AE2837E369Q39153362-800C390B-EF2E-47D1-BD37-09274F447DF3Q42332340-45A09E36-51B2-4D33-95E6-5771D83EBCFAQ47241391-B7099B24-A025-427B-BBDF-5F0FE86689CFQ50050998-A5A42B67-9699-4EE1-B672-DB049A4F8BCCQ51165460-089858C6-515C-42EB-BE16-A7017CBE98B5Q51166506-81F63FCA-A058-4664-8CF0-943ED6CE2B20Q53533493-B7F53D93-7EE0-4C49-A791-334AE03C64D6
P2860
Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dynamic progression of overact ...... symptoms: a systematic review.
@en
Dynamic progression of overact ...... symptoms: a systematic review.
@nl
type
label
Dynamic progression of overact ...... symptoms: a systematic review.
@en
Dynamic progression of overact ...... symptoms: a systematic review.
@nl
prefLabel
Dynamic progression of overact ...... symptoms: a systematic review.
@en
Dynamic progression of overact ...... symptoms: a systematic review.
@nl
P2093
P1433
P1476
Dynamic progression of overact ...... symptoms: a systematic review.
@en
P2093
Debra E Irwin
Ian Milsom
Michael B Chancellor
Zhonghong Guan
P304
P356
10.1016/J.EURURO.2010.06.007
P407
P577
2010-06-15T00:00:00Z